Stay updated on Avelumab Entinostat in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.

Latest updates to the Avelumab Entinostat in Ovarian Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a page update that does not change study details or data.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page footer revision version was incremented from v3.5.2 to v3.5.3, indicating a site release update rather than any modification to the clinical trial information.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision added: v3.5.2; revision v3.5.0 removed.SummaryDifference0.0%

- Check71 days agoChange DetectedRevision history updated: added revision v3.5.0 and removed revision v3.4.3.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision: v3.4.3 was added and v3.4.2 was removed.SummaryDifference0.0%

- Check107 days agoChange DetectedFallopian tube cancer was added to the conditions list, and the page revision was updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Avelumab Entinostat in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Entinostat in Ovarian Cancer Clinical Trial page.